Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Molecular and Cellular Biology
|
September 16, 2004
Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family
Viola Calabrò, Gelsomina Mansueto, Raffaela Santoro, et al.
Carcinogenesis
|
January 29, 2013
Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation
Raffaela Santoro, Federica Mori, Marina Marani, et al.
Omics : a Journal of Integrative Biology
|
February 26, 2011
Omics underpins novel clues on VDR chemoprevention target in breast cancer
Paola Muti, Barbara Benassi, Elisabetta Falvo, et al.
Journal of Gastric Cancer
|
January 4, 2020
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer
Alessandro Cavaliere, Valeria Merz, Simona Casalino, et al.
Molecular Cancer Therapeutics
|
September 29, 2019
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer
Raffaela Santoro, Marco Zanotto, Francesca Simionato, et al.
Oncotarget
|
March 12, 2016
Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
Federica Mori, Maria Ferraiuolo, Raffaela Santoro, et al.
Journal of Proteome Research
|
June 3, 2006
Quantitative proteomics identifies Gemin5, a scaffolding protein involved in ribonucleoprotein assembly, as a novel partner for eukaryotic initiation factor 4E
Ivo Fierro-Monti, Shabaz Mohammed, Rune Matthiesen, et al.
Cells
|
February 5, 2020
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Valeria Merz, Camilla Zecchetto, Raffaela Santoro, et al.
Oncoimmunology
|
September 22, 2017
A circulating T<sub>H</sub>2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
Geny Piro, Francesca Simionato, Carmine Carbone, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Molecular and Cellular Biology
|
September 16, 2004
Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family
Viola Calabrò, Gelsomina Mansueto, Raffaela Santoro, et al.
Carcinogenesis
|
January 29, 2013
Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation
Raffaela Santoro, Federica Mori, Marina Marani, et al.
Omics : a Journal of Integrative Biology
|
February 26, 2011
Omics underpins novel clues on VDR chemoprevention target in breast cancer
Paola Muti, Barbara Benassi, Elisabetta Falvo, et al.
Journal of Gastric Cancer
|
January 4, 2020
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer
Alessandro Cavaliere, Valeria Merz, Simona Casalino, et al.
Molecular Cancer Therapeutics
|
September 29, 2019
Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer
Raffaela Santoro, Marco Zanotto, Francesca Simionato, et al.
Oncotarget
|
March 12, 2016
Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects
Federica Mori, Maria Ferraiuolo, Raffaela Santoro, et al.
Journal of Proteome Research
|
June 3, 2006
Quantitative proteomics identifies Gemin5, a scaffolding protein involved in ribonucleoprotein assembly, as a novel partner for eukaryotic initiation factor 4E
Ivo Fierro-Monti, Shabaz Mohammed, Rune Matthiesen, et al.
Cells
|
February 5, 2020
From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer
Valeria Merz, Camilla Zecchetto, Raffaela Santoro, et al.
Oncoimmunology
|
September 22, 2017
A circulating T<sub>H</sub>2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
Geny Piro, Francesca Simionato, Carmine Carbone, et al.
Page
of 3